InvestorsHub Logo
Followers 373
Posts 16781
Boards Moderated 3
Alias Born 03/07/2014

Re: None

Sunday, 08/20/2017 10:11:31 PM

Sunday, August 20, 2017 10:11:31 PM

Post# of 106828
Article: BEWARE SCAM TRIALS..LOOK WHO's LISTED !!

Amazing article to me, written just recently on 7/27/2017. Quite a stunning read ...but more important, is LOOK WHO THE AUTHOR/EDITORS of said article name by name....NONE OTHER THAN "U.S. Stem Cell" and..and..and.."Ageless Regenerative Institute"....gee, wonder who's affiliated with, or was "connected" to good ole "Ageless" ?


http://vitals.lifehacker.com/beware-scam-clinical-trials-that-ask-you-to-pay-money-1797276243

Article in its entirety:
"
Beware Scam “Clinical Trials” That Ask You to Pay Money for Unproven Therapies

Beth Skwarecki, 7/27/2017

Clinical trials are how we test new medicines and therapies, and they can be a boon to patients: if current treatments haven’t worked for you, you can help to test out a new one. And as thanks for being a guinea pig, your medical costs are paid and you may even get some extra compensation.

But sketchy stem-cell clinics are now using the National Institutes of Health’s clinical trials registry, ClinicalTrials.gov, as a platform to advertise their pricey services. Ars Technica reports here on the findings from an analysis published in Regenerative Medicine that calls out problematic studies found on the site.

The registry is still legit—it’s an important way for scientists to keep track of trials—but some of the listings on it are from stem-cell clinics that charge patients to participate, and do not have approval from the FDA to test their treatments. Some describe themselves with words like “patient funded,” while others don’t explain that you have to pay until you’re signing up for the trial.

Pay-to-participate studies are fraught with ethical problems and often don’t make for good scientific findings anyway. They tend not to be published in peer-reviewed journals, they don’t compare the treatment with a placebo (nobody would pay thousands for a fake treatment, after all), and sometimes the scientific study never happens.


The problematic listings include studies by Ageless Regenerative Institute, Cell Surgical Network, Kimera Society Inc, Retina Associates of South Florida, MD Stem Cells, and StemGenix. StemGenix is currently facing a fraud lawsuit, and earlier this year three people lost their vision after paying US Stem Cell $5000 for stem-cell treatments that were listed as clinical trials.

There isn’t a surefire way to avoid sketchy clinics, but it’s good to be wary of “clinical trials” that ask you to pay a fee for your treatment."

END OF ARTICLE.

Now, that article CLEARLY NAMES "US Stem Cell" by name for the THREE BLIND LADIES case, as written about in THEE NEW ENGLAND JOURNAL OF MEDICINE...but it also names a place/biz called, "Ageless Regenerative Institute" too....Hmmmm

Florida Secretary of State site:


http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=EntityName&directionType=Initial&searchNameOrder=AGELESSREGENERATIVEINSTITUTE%20L100000765680&aggregateId=flal-l10000076568-05b3b01b-6943-4d6e-92e6-1270a4cbdffc&searchTerm=ageless%20regenerative&listNameOrder=AGELESSREGENERATIVECENTERPA%20P100000061830

Well LOOKY THERE, that is ole Dr Sharron McQuillan, Kristin Comella's ole pal and friend...and biz partner....imagine that?

See, here is an "annual LLC filing" for the ole "institute" and Kristin Comella is listed as a co-manager of the LLC, "Ageless Institute":


http://search.sunbiz.org/Inquiry/CorporationSearch/ConvertTiffToPDF?storagePath=COR%5C2011%5C0315%5C97958471.tif&documentNumber=L10000076568

SEE THAT ARTICLE BELOW, 2013, Comella is listed once again as "CHIEF SCIENCE OFFICER" ...for ANOTHER freaking private held LLC...like where have we seen that before...gee...trying to remember....LOL !

http://www.medicaltourismmag.com/stem-cell-treatments-hope-hype-or-true-regenerative-medicine/

Quote:

"Ms. Kristen Comella has over 14 years experience in corporate entities with expertise in regenerative medicine, training and education, research, product development, and senior management. Ms. Comella has been a member of the Bioheart Inc. senior management team since 2004 and is currently serving as the Chief Scientific Officer. Bioheart is a publically traded company focusing on the discovery, development and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease. Ms. Comella was appointed as Bioheart’s Vice President of R&D and Corporate Development in December 2008. Since joining Bioheart in September 2004, she has played a major role in managing the product development, manufacturing and quality systems. She is co-founder and Chief Executive Officer of Stemlogix, LLC and Chief Scientific Officer of the Ageless Regenerative Institute."

WOW, she's just all over the place..STEMLOGIX (another little LLC Comella filed/formed which became Vetbiologics essentially if one looks up the history...the animal thingy gig)...and AGELESS...and now working for GACP and.. NSI and... the Academy of Regenerative Practices...and..Advanced Stem Cell Rx (whatever the hell they even are?)...and gawd knows how many other PRIVATE LITTLE LLC's, always listed as their "CHIEF SCIENCE OFFICER" or whatever...while she also gets a massive base salary AND cash bonuses from this here little cash poor, nano sized sub 4 CENT penny stock, for which she's supposed to be thee "CHIEF SCIENCE OFFICER" and conducting all these clinical trials and whatnot.

MOST, MOST people I've ever seen and/or have known or read about- it would be a 60 to 80 hour a week position to be a Sr corp officer and "CHIEF SCIENCE OFFICER" and Board Member of just ONE, ONE public traded company that's supposedly doing, "WORLD LEADING CUTTING EDGE MEDICAL R&D" and, and, and claims to be "CONDUCTING MULTIPLE CLINICAL TRIALS" at the same time, etc

MAKES NO SENSE TO ME...not even 2.9 LOUSY CENTS WORTH...the Friday closing Bid price..


Posts are only my amateur opinions, personal views and thoughts. They are not any type of investment advice. Do one's own due diligence.